Cargando…
Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
Given the difficulty in obtaining adequate tissue in NSCLC, we investigated the utility of circulating tumor cells (CTCs) for MET status assessment in NSCLC patients. We used two platforms for CTC capture, and assessed MET expression in CTCs and matched-bronchial biopsies in patients with advanced-s...
Autores principales: | Ilie, Marius, Szafer-Glusman, Edith, Hofman, Véronique, Long-Mira, Elodie, Suttmann, Rebecca, Darbonne, Walter, Butori, Catherine, Lalvée, Salomé, Fayada, Julien, Selva, Eric, Yu, Wei, Marquette, Charles-Hugo, Shames, David S., Punnoose, Elizabeth, Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432243/ https://www.ncbi.nlm.nih.gov/pubmed/28212540 http://dx.doi.org/10.18632/oncotarget.15345 |
Ejemplares similares
-
High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness
por: Long, Elodie, et al.
Publicado: (2016) -
“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014) -
Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps
por: Ilie, Marius, et al.
Publicado: (2015) -
Circulating Tumor Cell Detection in Lung Cancer: But to What End?
por: Hofman, Véronique, et al.
Publicado: (2019) -
MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma
por: Bozec, Alexandre, et al.
Publicado: (2017)